NCT06211491

Brief Summary

In patients with spinal cord injury, the investigators want to understand and understand the differences in AD prevalence and characteristics according to bladder injection rate, and to determine which factors have a greater influence between bladder expansion or injection rate.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
8mo left

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress67%
Jan 2025Dec 2026

First Submitted

Initial submission to the registry

December 21, 2023

Completed
28 days until next milestone

First Posted

Study publicly available on registry

January 18, 2024

Completed
12 months until next milestone

Study Start

First participant enrolled

January 8, 2025

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2026

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Last Updated

January 14, 2026

Status Verified

January 1, 2026

Enrollment Period

1.6 years

First QC Date

December 21, 2023

Last Update Submit

January 12, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Bladder volume (ml)

    (1) at first AD at an infusion rate of 10 mL/min (2) at first AD at an infusion rate of 100 mL/min

    Immediately after the test

Secondary Outcomes (4)

  • Bladder compliance (mL/cmH2O)

    Immediately after the test

  • Symptoms (Y/N)

    Immediately after the test

  • Blood pressure (mmHg)

    Immediately after the test

  • Heart rate (bpm)

    Immediately after the test

Interventions

Urodynamic testing is performed using saline solution at the same temperature as body temperature (37 degrees) at two injection speeds of 10 mL/min and 100 mL/min, respectively.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Chronic spinal cord injuries

You may qualify if:

  • Patients with chronic spinal cord injury 6 months after receiving the award
  • Patients with confirmed AD due to bladder fullness in previous urodynamic test
  • Patients confirmed to have neurological damage level C1-T6, AIS A or B

You may not qualify if:

  • Patients who cannot perform the test because their systolic blood pressure remains at 150 mmHg during the urodynamic test
  • Patients who cannot undergo testing due to hemodynamic instability
  • Patients who cannot undergo testing due to overt urinary tract infection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pusan National University Yangsan Hospital

Yangsan, Gyeongsangnam-do, 50612, South Korea

RECRUITING

MeSH Terms

Conditions

Spinal Cord InjuriesAutonomic Dysreflexia

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and InjuriesAutonomic Nervous System Diseases

Study Officials

  • Sungchul Huh, Ph.D

    Pusan National University Yangsan Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sungchul Huh, Ph.D

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

December 21, 2023

First Posted

January 18, 2024

Study Start

January 8, 2025

Primary Completion (Estimated)

August 30, 2026

Study Completion (Estimated)

December 30, 2026

Last Updated

January 14, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations